Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and traditional Chinese medicines under the Shouxiangu brand name. It is also involved in the wholesale and retail; technology research and development; and real estate business. The company was founded in 1909 and is headquartered in Jinhua, China.
Research context
Zhejiang Shouxiangu Pharmaceutical Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Zhejiang Shouxiangu Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 1.0% below its 200 day moving average.
From a valuation standpoint, the stock is 12.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd's total revenue sank by 22.3% to $158M since the same quarter in the previous year.
Its net income has dropped by 63.1% to $25M since the same quarter in the previous year.
Finally, its free cash flow fell by 5.7% to $60M since the same quarter in the previous year.
Based on the above factors, Zhejiang Shouxiangu Pharmaceutical Co., Ltd gets an overall score of 1/5.